#May/June 2016, #2016, #Exports
The life-saving role played by Indian pharmaceutical firms in poorer countries of Africa is one of the real global success stories of our time.
The year: 2001. Africa was facing a major health crisis. Sub-Saharan Africa alone had 22.5 million HIV-positive people. The disease was assuming epidemic proportions. The price of patented drugs supplied by western drug companies was a prohibitive $10,000 per patient per year – way out of reach of the average patient.
#May/June 2016, #Africa, #2016
India-Africa trade jumped from just $1 billion in 2001 to $71.4 billion in 2014-15. It is one of the success stories for Indian industry in developing and expanding an emerging market and highlights the benefits of South-South cooperation.
#Guest Column, #September 2015
The core here is that incremental and evolutionary can co-exist and every effort we make in Evolutionary doesn’t need to be pulled down by the potential opportunity cost of not looking at incremental.